IOF.L

Iofina Plc
Iofina PLC - IO#10 Iodine Plant Commissioned
13th September 2024, 06:00
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 0424E
Iofina PLC
13 September 2024
 

13 September 2024

Iofina plc

("Iofina", the "Group", or the "Company")

(AIM: IOF)

 

IO#10 Iodine Plant Commissioned

 

Iofina plc (AIM: IOF), specialists in the exploration and production of iodine and manufacturers of specialty chemical products, is pleased to announce that the Company's IO#10 IOsorb® plant is now commissioned. The new plant is undergoing hydro-testing and brine water is flowing through its system. In the coming days, in line with the planned project timings, IO#10 will shortly begin concentrating and isolating iodine, with production set to ramp up over the coming weeks.

IO#10 is the Company's seventh plant currently operating in Oklahoma, constructed with a new partner and in Iofina's new core area where oil and gas drilling activity is high. The new plant is expected to make a material contribution to crystalline iodine production through the end of the year, with the capacity to produce 100-150MT per annum.

 

Photo: IO#10 in Oklahoma, USA

 

Commenting, President and CEO, Dr. Tom Becker stated:

"IO#10 is another major milestone in our growth plans. The new plant is set to make a material contribution to Iofina's total crystalline iodine production through the remainder of the year. We continue to advance discussions with our chosen brine water partner for our next plant, IO#11, and will make a further update on this soon." 

 

Enquiries:

 

Dr. Tom Becker

CEO & President

Iofina plc

Tel: +44 (0)20 3006 3135

 

Nomad & Broker:

Henry Fitzgerald-O'Connor/Harry Rees

Canaccord Genuity Limited

Tel: +44 (0)20 7523 8000

  

Media Contact:

Charles Goodwin/Shivantha Thambirajah/Zara McKinlay

Yellow Jersey PR Limited

Tel: +44 (0)7747 788 221/+44 (0)7983 521 488

 

About Iofina:

Iofina plc (AIM: IOF) is a vertically integrated company that specialises in the production of Iodine and the manufacturing of specialty chemical products. Iofina is the second largest producer of iodine in North America and operates the manufacturing entities Iofina Resources and Iofina Chemical.

 

LEI: 213800QDMFYVRJYYTQ84

 

ISIN: GB00B2QL5C79

 

Iofina Resources

Iofina Resources develops, builds, owns, and operates iodine extraction plants using Iofina's WET® IOsorb® technology. Iofina currently operates six producing IOsorb® plants in Oklahoma and is consistently using technology and innovation to improve and expand its operations.

 

Iofina Chemical

Iofina Chemical has manufactured high-quality halogen speciality chemicals derived from raw iodine, as well as non-iodine-based products. Iofina Chemical celebrated its 40th anniversary in 2023 as a preeminent halogen-based specialty chemicals company.

 

www.iofina.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUUUKRSRUKAAR]]>
TwitterFacebookLinkedIn